navigation
total 1518 publications found
filter by journal
| view | year | title | authors |
|---|---|---|---|
| 2025 | Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study. | Elvstam O; Ryom L; Neesgaard B; Tau L; Gunthard HF; Zangerle R; Vehreschild JJ; Wit F; Sonnerborg A; Kovari H; Abutidze A; Petoumenos K; Jaschinski N; Hosein S; Bogner J; Grabmeier-Pfistershammer K; Garges H; Rooney J; Young L; Law M; Kirk O; and the Swiss HIV Cohort Study | |
| 2025 | Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function. | Audige A; Amstutz A; Schuurmans MM; Amico P; Braun DL; Stoeckle MP; Hasse B; Hage R; Damm D; Tamm M; Mueller NJ; Gunthard HF; Koller MT; Schonenberger CM; Griessbach A; Labhardt ND; Kouyos RD; Trkola A; Huber M; Kusejko K; Bucher HC; Abela IA; Briel M; Chammartin F; Speich B; and the Swiss HIV Cohort Study | |
| 2025 | Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity. | Foulkes C; Friedrich N; Ivan B; Stiegeler E; Magnus C; Schmidt D; Karakus U; Weber J; Gunthard HF; Pasin C; Rusert P; Trkola A; and the Swiss HIV Cohort Study | |
| 2025 | Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium. | Rupasinghe D; Bansi-Matharu L; Law M; Zangerle R; Rauch A; Tarr PE; Greenberg L; Neesgaard B; Jaschinski N; De Wit S; Wit F; d'Arminio Monforte A; Fontas E; Castagna A; Stecher M; Florence E; Begovac J; Mussini C; Sonnerborg A; Abutidze A; Groh A; Vannappagari V; Cohen C; Young L; Hosein S; Ryom L; Petoumenos K; and the Swiss HIV Cohort Study | |
| 2025 | Harmonization of alcohol use data and mortality across a multi-national HIV cohort collaboration. | Ingle SM; Trickey A; Lankina A; McGinnis KA; Justice A; Cavassini M; d' Arminio Monforte A; van Sighem A; Gill MJ; Crane HM; Obel N; Jarrin I; Wallner E; Guest J; Silverberg MJ; Vourli G; Wittkop L; Sterling TR; Satre DD; Burkholder GA; Costagliola D; Sterne JAC; and the Swiss HIV Cohort Study | |
| 2025 | Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV. | Wrona A; Justice AC; Tate JP; Rentsch CT; Gordon KS; Kidwai-Khan F; Silverberg MJ; Satre DD; Marconi VC; Ingle SM; Sterne JAC; Cavassini M; Bryant K; McGinnis KA; and the Swiss HIV Cohort Study | |
| 2025 | Late re-engagement into HIV care among adults in the Swiss HIV Cohort Study. | Haas AD; Kusejko K; Cavassini M; Gunthard H; Stockle M; Calmy A; Bernasconi E; Schmid P; Egger M; Wandeler G; and the Swiss HIV Cohort Study | |
| 2025 | Threshold sensitivity analysis for HIV-1 transmission cluster detection using different genomic regions and subtypes. | Obeng BM; Kouyos RD; Kusejko K; Salazar-Vizcaya L; Gunthard HF; Kelleher AD; Di Giallonardo F; and the Swiss HIV Cohort Study | |
| 2025 | Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study. | Hilfiker A; Schoepf IC; Avery EF; Ledergerber B; Colin-Benoit E; Riebensahm C; Marzolini C; Kahlert CR; Bernasconi E; Cavassini M; Marinosci A; Gunthard HF; Kouyos R; Nemeth J; Tarr PE; and the Swiss HIV Cohort Study | |
| 2025 | Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort study. | Kraef C; Roen A; Podlekareva D; Bakowska E; Nemeth J; Knappik M; Payen MC; Wit F; Mussini C; d'Arminio Monforte A; Castagna A; Chkhartishvili N; Neesgaard B; Jaschinski N; Anne AV; Borodulina E; Ballif M; Wallner E; Israelski D; Garges H; Mocroft A; Kirk O; and the Swiss HIV Cohort Study | |
| 2025 | Polygenic Risk Scores for Type 2 Diabetes in the Swiss HIV Cohort Study. | Labarile M; Thorball CW; Hodel F; Fellay J; Tepekule B; Calmy A; Stockle M; Damonti L; Surial B; Cavassini M; Bernasconi E; Notter J; Gunthard HF; Nemeth J; Tarr PE; Pasin C; Kouyos RD; and the Swiss HIV Cohort Study | |
| 2025 | Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design. | Groen K; Kuratli R; Enkelmann J; Fernbach S; Wendel-Garcia PD; Staiger WI; Lejeune M; Sauras-Colon E; Roche-Campo F; Filippidis P; Rauch A; Trkola A; Gunthard HF; Kouyos RD; Brugger SD; Hale BG; and the Swiss HIV Cohort Study | |
| 2025 | Outcomes After Prenatal Exposure to Raltegravir-Containing Antiretroviral Therapy: A Multicohort European Study. | Sconza R; Fernandes G; Bailey H; Peters H; Prieto Tato LM; Illan Ramos M; Aebi-Popp K; Kahlert C; Gamell AM; Frick A; Ene L; Samarina A; Thorne C; and the Swiss HIV Cohort Study | |
| 2025 | Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C. | Young J; Wang S; Sacks-Davis R; Stewart A; van Santen DK; van der Valk M; Doyle JS; Matthews G; Berenguer J; Wittkop L; Lacombe K; Rauch A; Stoove M; Hellard M; Klein MB; and the Swiss HIV Cohort Study | |
| 2025 | Perspective: clinical relevance of epigenetic aging and HIV. | Schoepf IC; Haerry D; Esteban-Cantos A; Arribas JR; Tarr PE; and the Swiss HIV Cohort Study | |
| 2025 | Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. | Han WM; Ryom L; Sabin CA; Greenberg L; Cavassini M; Egle A; Duvivier C; Wit F; Mussini C; d'Arminio Monforte A; Castagna A; Miro JM; van der Valk M; Bonnet F; Pradier C; Skocic M; Matulionyte R; Stockle M; Jaschinski N; Timiryasova A; Tallada J; Rogatto FP; Vannappagari V; Young LA; Lundgren JD; Petoumenos K; Hoy JF; and the Swiss HIV Cohort Study | |
| 2025 | Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection. | Beguelin C; Surial B; Hofmann E; Begre L; Munting A; Gunthard HF; Stockle M; Bernasconi E; Schmid P; Calmy A; Suter-Riniker F; Rauch A; Wandeler G; and the Swiss HIV Cohort Study | |
| 2025 | Long-term non-progression in children with HIV: estimates from international cohort data. | Jackson C; Crichton S; Judd A; Bamford A; Goulder P; Klein N; Marques L; Paioni P; Riordan A; Spoulou V; Vieira VA; Ansone S; Chiappini E; Le Coeur S; Ene L; Galli L; Giaquinto C; Goetghebuer T; Fortuny C; Kanjanavanit S; Marczynska M; Navarro M; Naver L; Ngo-Giang-Huong N; Plotnikova YK; Plynskey AA; Ramos JT; Raus I; Rozenberg VY; Samarina AV; Scholvinck EH; Vasylenko N; Volokha A; Collins IJ; Goodall R; and the Swiss HIV Cohort Study | |
| 2025 | Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database. | Zeeb M; Frischknecht P; Balakrishna S; Jorimann L; Tschumi J; Zsichla L; Chaudron SE; Jaha B; Neumann K; Leemann C; Huber M; Leuzinger K; Gunthard HF; Metzner KJ; Kouyos RD; and the Swiss HIV Cohort Study | |
| 2025 | Viral suppression, viral failure and safety outcomes in children and adolescents living with HIV on dolutegravir in Europe and Thailand. | Scott K; O'Rourke J; Jackson C; Ene L; Galli L; Goetghebuer T; Henegar C; Konigs C; Marczynska M; Naver L; Noguera-Julian A; Paioni P; Ramos JT; Smith B; Songtaweesin WN; Spoulou V; Tantawarak N; Turkova A; Vannappagari V; Volokha A; Bamford A; Castro H; Chappell E; Dalla Valle G; Foster C; Guillen Martin S; Prieto Tato LM; Puthanakit T; Sherstiuk H; Shkurka I; Soeria-Atmadja S; Judd A; Crichton S; Collins IJ; and the Swiss HIV Cohort Study | |
| 2025 | Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study. | Loosli T; Han N; Hauser A; Josi J; Ingle SM; van Sighem A; Wittkop L; Vehreschild J; Ceccherini-Silberstein F; Maartens G; Gill MJ; Sabin CA; Johnson LF; Lessells R; Gunthard HF; Egger M; Kouyos RD; and the Swiss HIV Cohort Study | |
| 2025 | Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data. | Bartl L; Zeeb M; Kalin M; Loosli T; Notter J; Furrer H; Hoffmann M; Hirsch HH; Zangerle R; Grabmeier-Pfistershammer K; Knappik M; Calmy A; Fernandez JD; Labhardt ND; Bernasconi E; Gunthard HF; Kouyos RD; Kusejko K; Nemeth J; and the Swiss HIV Cohort Study | |
| 2025 | Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development. | Hesselman MC; Zeeb M; Rusert P; Pasin C; Mamrosh J; Kariuki S; Pichler I; Sickmann M; Kaufmann MM; Schmidt D; Friedrich N; Metzner KJ; Rindler A; Kuster H; Adams C; Thebus R; Huber M; Yerly S; Leuzinger K; Perreau M; Koller R; Dollenmaier G; Frigerio S; Westfall DH; Deng W; deCamp AC; Juraska M; Edupuganti S; Mgodi N; Murrell H; Garrett N; Wagh K; Mullins JI; Williamson C; Moore PL; Gunthard HF; Kouyos RD; Trkola A; and the Swiss HIV Cohort Study | |
| 2025 | Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort. | Harney BL; Sacks-Davis R; van Santen DK; Stewart AC; Matthews GV; Carson JM; Klein MB; Lacombe K; Wittkop L; Salmon D; Leleux O; Merchadou L; van der Valk M; Smit C; Prins M; Boyd A; Berenguer J; Jarrin I; Rauch A; Hellard ME; Doyle JS; and the Swiss HIV Cohort Study | |
| 2024 | Long-term trends in hepatitis C prevalence, treatment uptake and liver- related events in the Swiss HIV Cohort Study. | Baumann L; Braun DL; Cavassini M; Stoeckle M; Bernasconi E; Schmid P; Calmy A; Haerry D; Beguelin C; Fux CA; Wandeler G; Surial B; Rauch A; and the Swiss HIV Cohort Study |